A pathogenic germline BRCA2 variant in a patient with hypopharyngeal squamous cell carcinoma

Abstract Pathogenic germline BRCA2 variants may be associated with an increased risk of hypopharyngeal squamous cell carcinoma that is more responsive to chemoradiation and chemotherapeutics targeting defective double‐strand DNA repair.

Bibliographic Details
Main Authors: Tatiana Correa, Douglas E. Laux, Henry T. Hoffman
Format: Article
Language:English
Published: Wiley 2021-01-01
Series:Clinical Case Reports
Subjects:
Online Access:https://doi.org/10.1002/ccr3.3548
_version_ 1818437675321917440
author Tatiana Correa
Douglas E. Laux
Henry T. Hoffman
author_facet Tatiana Correa
Douglas E. Laux
Henry T. Hoffman
author_sort Tatiana Correa
collection DOAJ
description Abstract Pathogenic germline BRCA2 variants may be associated with an increased risk of hypopharyngeal squamous cell carcinoma that is more responsive to chemoradiation and chemotherapeutics targeting defective double‐strand DNA repair.
first_indexed 2024-12-14T17:28:26Z
format Article
id doaj.art-bf20a32bc1a14a3293f7296f6948d8f1
institution Directory Open Access Journal
issn 2050-0904
language English
last_indexed 2024-12-14T17:28:26Z
publishDate 2021-01-01
publisher Wiley
record_format Article
series Clinical Case Reports
spelling doaj.art-bf20a32bc1a14a3293f7296f6948d8f12022-12-21T22:53:09ZengWileyClinical Case Reports2050-09042021-01-019142943210.1002/ccr3.3548A pathogenic germline BRCA2 variant in a patient with hypopharyngeal squamous cell carcinomaTatiana Correa0Douglas E. Laux1Henry T. Hoffman2Department of Otolaryngology – Head and Neck Surgery University of Iowa Iowa City IA USADepartment of Internal Medicine–Hematology, Oncology & Bone Marrow Transplant University of Iowa Iowa City IA USADepartment of Otolaryngology – Head and Neck Surgery University of Iowa Iowa City IA USAAbstract Pathogenic germline BRCA2 variants may be associated with an increased risk of hypopharyngeal squamous cell carcinoma that is more responsive to chemoradiation and chemotherapeutics targeting defective double‐strand DNA repair.https://doi.org/10.1002/ccr3.3548geneticshead and neckmolecular targeted therapiesoncologypharmacology
spellingShingle Tatiana Correa
Douglas E. Laux
Henry T. Hoffman
A pathogenic germline BRCA2 variant in a patient with hypopharyngeal squamous cell carcinoma
Clinical Case Reports
genetics
head and neck
molecular targeted therapies
oncology
pharmacology
title A pathogenic germline BRCA2 variant in a patient with hypopharyngeal squamous cell carcinoma
title_full A pathogenic germline BRCA2 variant in a patient with hypopharyngeal squamous cell carcinoma
title_fullStr A pathogenic germline BRCA2 variant in a patient with hypopharyngeal squamous cell carcinoma
title_full_unstemmed A pathogenic germline BRCA2 variant in a patient with hypopharyngeal squamous cell carcinoma
title_short A pathogenic germline BRCA2 variant in a patient with hypopharyngeal squamous cell carcinoma
title_sort pathogenic germline brca2 variant in a patient with hypopharyngeal squamous cell carcinoma
topic genetics
head and neck
molecular targeted therapies
oncology
pharmacology
url https://doi.org/10.1002/ccr3.3548
work_keys_str_mv AT tatianacorrea apathogenicgermlinebrca2variantinapatientwithhypopharyngealsquamouscellcarcinoma
AT douglaselaux apathogenicgermlinebrca2variantinapatientwithhypopharyngealsquamouscellcarcinoma
AT henrythoffman apathogenicgermlinebrca2variantinapatientwithhypopharyngealsquamouscellcarcinoma
AT tatianacorrea pathogenicgermlinebrca2variantinapatientwithhypopharyngealsquamouscellcarcinoma
AT douglaselaux pathogenicgermlinebrca2variantinapatientwithhypopharyngealsquamouscellcarcinoma
AT henrythoffman pathogenicgermlinebrca2variantinapatientwithhypopharyngealsquamouscellcarcinoma